Navigation Links
MiddleBrook Pharmaceuticals Hires Key Commercial Team Members
Date:11/19/2008

ill enable them to quickly execute our plan to hire our national field force representatives, begin sales training and prepare for the launch of Moxatag, the first and only FDA-approved once-daily amoxicillin."

About Moxatag:

Moxatag (amoxicillin extended-release) Tablets, 775mg, is a once-a-day extended-release formulation of amoxicillin for oral administration consisting of three components: one immediate-release component and two delayed-release components. The three components of Moxatag are combined in a specific ratio to prolong the release of amoxicillin compared to immediate-release amoxicillin. Moxatag is intended to provide a lower treatment dose, once- daily alternative to currently approved penicillin and amoxicillin regimens for the treatment of adults and pediatric patients 12 years and older with tonsillitis and/or pharyngitis. For more information about Moxatag, please visit www.middlebrookpharma.com.

About MiddleBrook Pharmaceuticals:

MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is a pharmaceutical company focused on developing and commercializing anti-infective products that fulfill unmet medical needs. We are currently developing a portfolio of anti-infective products utilizing our proprietary, once-a-day pulsatile delivery technology called Pulsys. Our near-term corporate strategy is to improve dosing regimens and/or frequency of dosing which we believe will result in improved patient dosing convenience and compliance for antibiotics that have been used and trusted by physicians and patients for decades. The Company currently markets the Keflex brand of cephalexin and has received regulatory approval for Moxatag - the first and only once-daily amoxicillin product approved for marketin
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
2. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
3. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
4. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
5. MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
6. MiddleBrook Hires TalenTactics to Recruit National Field Force
7. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
8. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015  Approximately 1% of the ... into their chromosomes. These individuals are three times more ... published in one of the nation,s leading medical journals ... in Canada.  Photo - http://photos.prnewswire.com/prnh/20150706/230685 ... 6 (HHV-6) causes roseola (also known as "sixth disease") ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... cheaper molecular diagnostic tests are key drivers of the global molecular diagnostics market. ... medicine and the introduction of new companion diagnostic tests will increase demand for ...
(Date:7/6/2015)... 2015  Viveve Medical, Inc. ("Viveve") (OTCQB: VIVMF), a company focused ... Viveve,s Chief Executive Officer, and Scott Durbin , Viveve,s ... 9, 2015. , , , DATE:    , ... , TIME:     , , , 12:15 PM EDT ... http://tinyurl.com/viveve   ,    ...
(Date:7/6/2015)... LOS ANGELES , July 6, 2015 ... the establishment of an agreement with Novella Clinical ... of ICT-107 in patients with newly diagnosed glioblastoma. Novella ... clinical trial services to small to mid-sized oncology companies. ... clinical sites in the US, Europe ...
Breaking Biology Technology:Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 2Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 3Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 2Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 3Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2
... of the,Battelle National Biodefense Institute, LLC raised enough ... School Board,s Community Agency,School Services., "Having the ... that some,parents are challenged with given the cost," ... working for several years to provide all children ...
... with NASDAQ; Stock Symbol ,OGXI, Implements ... while focusing on clinical pipeline programs ... OncoGenex,Pharmaceuticals, Inc. (formerly Sonus Pharmaceuticals, Inc.) (NASDAQ: ... Company has completed its acquisition of,OncoGenex Technologies ...
... FRANCISCO, Aug. 21 Medizone,International, Inc. (Pink Sheets: ... M.Sc., M.D. to its Board of Directors. Dr.,Shannon ... Canada,which included advanced training in surgery and sports ... physiology. He has been,actively engaged in applied medical ...
Cached Biology Technology:BNBI Employees Donate 1,000 Backpacks to Frederick County School Children 2Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today 2Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today 3Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today 4Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today 5Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today 6Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors 2Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors 3
(Date:6/25/2015)... DALLAS , June 25, 2015 ... report "Fingerprint Sensors Market by Type (Swipe & Area), Technology, ... (Mobile, Government, Healthcare, Commercial Security & Others) & ... published by marketsandmarkets, the said market is expected ... CAGR of 17.1%. Browse 76 ...
(Date:6/24/2015)... June 24, 2015 This report provides market ... next six years. It contains an analysis of the ... with their impact from the short, medium, and long ... the industry, market, and technology trends that currently, prevail ... of concerned authorities to efficiently manage the increasing marine ...
(Date:6/23/2015)... , June 23, 2015   MedNet Solutions ... supports the entire spectrum of clinical research, is ... ™ , the company,s intuitive, flexible and ... a Silver 2015 Stevie® Award by the ... & Services Website category.  The American Business Awards ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... circumcision reduces the abundance of bacteria living on the penis ... against HIV, according to a study led by the Translational ... significant shift in the bacterial community or microbiome of the ... journal mBio . This international collaboration focused on ...
... 2013 - BGI, the world,s largest genomics organization, ... in the Americas (ICG Americas 2013) on September ... by University of California, Davis, will feature presentations ... to new approaches in sequencing and bioinformatics, and ...
... woolly mammoths wandering around the ancient spruce woodlands ... predicting how species could respond to climate change? ... for Environmental Science,s Appalachian Laboratory, along with researchers ... of California-Merced, have received a three-year, $670,000 award ...
Cached Biology News:TGen-led study discovers dramatic changes in bacteria following male circumcision 2BGI hosts its '2nd International Conference on Genomics in the Americas' 2Scientists look to ancient past to better predict how species may respond climate change 2
...
EPA II Buffer is a diluent formulated to stabilize the activity of Chemicon horseradish peroxidase (HRP)-antibody conjugates at high conjugate dilution for extended periods....
... color screen, without Camera • ... 8.0 mega pixel resolution. It is computer free ... image from large 5.6" TFT color liquid crystal ... to capture image for fluorescent gels, colorimetric gels, ...
...
Biology Products: